MAPT and type 2 diabetes mellitus: There are many preclinical studies relating not only T2DM, but also type 1 diabetes with increased tau phosphorylation [298,299,300], and increased levels of tau have been found in CSF of type 2 diabetic patients compared with normal patients [301].